Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model

Published:2020-04 Issue: Volume:218 Page:16-28
ISSN:1931-5244
Container-title:Translational Research
language:en
Short-container-title:Translational Research

Author:

Toots Mart,Yoon Jeong-Joong,Hart Michael,Natchus Michael G.,Painter George R.,Plemper Richard K.

Funder

NIH

NIAID

Publisher

Elsevier BV

Subject

Biochemistry, medical,Public Health, Environmental and Occupational Health,General Medicine,Physiology (medical)

Reference52 articles.

1. Annual estimates of the burden of seasonal influenza in the United States: a tool for strengthening influenza surveillance and preparedness;Rolfes;Influenza Other Respir Viruses,2018

2. How high is a high risk? Prioritising high-risk individuals in an influenza pandemic;Littmann;Vaccine,2014

3. Update: influenza activity in the United States during the 2017-18 season and composition of the 2018-19 influenza vaccine;Garten;MMWR Morb Mortal Wkly Rep,2018

4. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis;Osterholm;Lancet Infect Dis,2012

5. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies;Belongia;Lancet Infect Dis,2016

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encapsulation investigation of molnupiravir drug guest using cucurbituril hosts through the DFT approach;Journal of Inclusion Phenomena and Macrocyclic Chemistry;2024-07-02

2. A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy;Bioorganic Chemistry;2024-06

3. New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses;Antiviral Research;2024-05

4. Enabling privacy-preserving medication analysis in distributed EHR systems;Journal of Information Security and Applications;2024-05

5. Respiratory virus coinfections during the COVID-19 pandemic: epidemiologic analysis and clinical outcomes from the Phase 2/3 molnupiravir trial (MOVe-OUT);Microbiology Spectrum;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3